chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling cold, Heart rate increased, Inflammation, Injection site swelling, Pain in extremity
Clinical narrative: On October 5th I had a fever, chills, sore arm, swelling  at injection site, before going to bed. Woke up at 2:00am with strong heart palpitations, chest pain, increased pulse rate, very light headed and dizzy. Contacted my dr and made an appointment, he did chest x-ray and blood test for cardiac  markers such as triponin etc. suspected pericarditis and started a course of steroid to reduce inflammation. After several  days on steroids it had not improved much so I went to the ER and they did ct scan looking for blood clots and re checked blood work. No clots and labs were all good. Symptoms appear to be consistent with postural orthostatic tachycardia syndrome.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Pericarditis, Postural orthostatic tachycardia syndrome, Pyrexia
Clinical narrative: On October 5th I had a fever, chills, sore arm, swelling  at injection site, before going to bed. Woke up at 2:00am with strong heart palpitations, chest pain, increased pulse rate, very light headed and dizzy. Contacted my dr and made an appointment, he did chest x-ray and blood test for cardiac  markers such as triponin etc. suspected pericarditis and started a course of steroid to reduce inflammation. After several  days on steroids it had not improved much so I went to the ER and they did ct scan looking for blood clots and re checked blood work. No clots and labs were all good. Symptoms appear to be consistent with postural orthostatic tachycardia syndrome.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Lymph node pain, Lymphadenopathy
Clinical narrative: Swelling of lymph nodes in the arm pit area of both arms. Soreness and pain in both shoulder joints. Sensitivity and pain in both arm pits.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Pain of skin, Skin burning sensation
Clinical narrative: Immediately after administration, entire left arm was burning and stinging from shoulder to fingertips. Symptoms still present about 5 weeks after second vaccination.
Age: 50.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: No adverse event
Clinical narrative: patient reported egg allergy and chicken allergy - monitored for 30 minutes with no reaction post administration
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Aphthous ulcer, Cheilitis, Discomfort, Feeding disorder, Glossodynia
Clinical narrative: Mouth is full of sores, like canker sores. Red rings with white center, do not ulcer into the tissue. All over tongue, inside the lips, and cheeks. 100?s of these clusters vary in size causing extreme discomfort with burning feeling. Make it so that speaking and eating are difficult to not possible.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Oral discomfort, Speech disorder, Stomatitis
Clinical narrative: Mouth is full of sores, like canker sores. Red rings with white center, do not ulcer into the tissue. All over tongue, inside the lips, and cheeks. 100?s of these clusters vary in size causing extreme discomfort with burning feeling. Make it so that speaking and eating are difficult to not possible.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products, No adverse event
Clinical narrative: Individual presented at community covid-19 booster event.  Reported having Pfizer vaccine series, 3/1/21 and 3/24/21 and presented covid-19 vaccine card with same information.  Following event this RN entered patient record which reflected Pfizer covid-19 vaccines 3/1/21 and 3/24/21 and Janssen vaccine 6/2/21 prior to 10/30/21 Moderna booster (0.25ml).  Sought guidance from facility Infectious Disease physician who suggested contacting patient and completing VAERS reports.. Called patient who states he is "fine" and has not experienced side effects from vaccine 48 hours prior.  Patient  now states that he is aware he received more covid-19 vaccines than recommended and understands he should not request or receive additional doses.  He says he has 3 separate covid-19 vaccine cards.  He was advised to update his providers of dates of all covid-19 vaccines and to contact PCP with any further questions or concerns or changes to health status. He was also encouraged to seek assistance at time of next  medical appointment to consolidate information on multiple vaccine cards so he has a single, accurate card.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Induration, Inflammation, Injection site mass
Clinical narrative: I got a lump in my armpit at the vaccination site a couple of days after I got my second shot of the Pfizer COVID vaccine. A month and a half I started having breast pain on the same side of my body. My doctor found hardened tissue and said it might be the result of the inflammation caused by the vaccine.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Loss of personal independence in daily activities, Pain, Pain in extremity
Clinical narrative: Felt sore and pain moving  left arm after second shot August 13th 2021.  Thought it would go away within a week.  Went to see the doctor a month later when I had limited motion and extreme pain of the left arm when doing daily activities such as washing hair and getting dressed.  Doctor prescribed a week of steroids and going to Physical Therapy.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Injection site rash, Pain in extremity, Rash
Clinical narrative: Sore arm still present after 48 hours. Mild skin rash at injection site still present after 48 hours. Very mild flu-like symptoms onset after 24 hours diminishing after 36 hours.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory, Full blood count
Clinical narrative: Heart palpitations, muscle spasms/twitching, anxiety, numbness/tingling, and elevated platelets
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscle spasms, Muscle twitching, Palpitations, Paraesthesia
Clinical narrative: Heart palpitations, muscle spasms/twitching, anxiety, numbness/tingling, and elevated platelets
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Platelet count increased
Clinical narrative: Heart palpitations, muscle spasms/twitching, anxiety, numbness/tingling, and elevated platelets
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram, Pain, Pericarditis, Troponin
Clinical narrative: Diagnosed with Pericarditis as an adverse affect of the COVID-19 Vaccine. Was in the E.R for 2 nights and my troponin levels were high reaching 2.71 %. Was put on colchicine, prilosec, and ibuprofen. Still in pain after 2 weeks of pain starting. Was told pain should subside by 3 weeks.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound scan, Vaccination complication
Clinical narrative: Diagnosed with Pericarditis as an adverse affect of the COVID-19 Vaccine. Was in the E.R for 2 nights and my troponin levels were high reaching 2.71 %. Was put on colchicine, prilosec, and ibuprofen. Still in pain after 2 weeks of pain starting. Was told pain should subside by 3 weeks.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Mobility decreased, Pain in extremity
Clinical narrative: Patient called Monday Morning 11/01/2022 complaining about severe pain in her. right shoulder, having difficulty moving it It started in both arms but left as better right is still hurting Tried Tylenol, Advil, no improvement
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Cardiac stress test, Chest X-ray, Computerised tomogram thorax abnormal, Dyspnoea
Clinical narrative: Shortness of breath less than two weeks after second shot, continuing until present day (11.01.2021). I cannot walk more than 250 ft. without pausing to catch my breath.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Full blood count, Haemoglobin, Prothrombin time, Pulmonary embolism
Clinical narrative: Shortness of breath less than two weeks after second shot, continuing until present day (11.01.2021). I cannot walk more than 250 ft. without pausing to catch my breath.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary function test
Clinical narrative: Shortness of breath less than two weeks after second shot, continuing until present day (11.01.2021). I cannot walk more than 250 ft. without pausing to catch my breath.
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient here to receive Booster after J&J 1st shot 6 mos. ago. Requested Moderna for 2nd shot. Patient given .5ml Moderna instead of .25ml. Due to miscommunication. No adverse reactions observed.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Extra dose administered, Influenza like illness, Vaccination site pain
Clinical narrative: Received third dose without being immunocompromised; Received full dose 0.5 ml booster; Flu like symptoms for about 8 hours; Large tender area belowinjection site on arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms for about 8 hours), VACCINATION SITE PAIN (Large tender area belowinjection site on arm), EXTRA DOSE ADMINISTERED (Received third dose without being immunocompromised) and ACCIDENTAL OVERDOSE (Received full dose 0.5 ml booster) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms for about 8 hours). October 2021, the patient experienced VACCINATION SITE PAIN (Large tender area belowinjection site on arm). On 17-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Received full dose 0.5 ml booster). On 18-Oct-2021, the patient experienced EXTRA DOSE ADMINISTERED (Received third dose without being immunocompromised). On 17-Oct-2021, ACCIDENTAL OVERDOSE (Received full dose 0.5 ml booster) had resolved. On 18-Oct-2021, EXTRA DOSE ADMINISTERED (Received third dose without being immunocompromised) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms for about 8 hours) and VACCINATION SITE PAIN (Large tender area belowinjection site on arm) outcome was unknown.            No concomitant and treatment information were reported by the reporter.   This case was linked to MOD-2021-360706 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Oct-2021: New events were added
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, COVID-19 pneumonia, Cough, Decreased appetite
Clinical narrative: Narrative: 74yo M was admitted from the emergency room due to progressive shortness x 5 days after having a COVID exposure. Patient is fully vaccinated but reports approximately 10 days ago he was around a boy who was coughing a lot. Over the past 2-3 days his wife has been ill and plans to go now to get tested for covid. Patient reported taking otc cough medication and benadryl to assist with sleep, without any relief. Symptoms reported; +nonproductive cough, +wheezing, +DOE, sob, +subjective fever, +hot/cold flashes, right sided generalize pain to include right side of abdomen, decreased appetite, no food intake in 2-3d, 1 loose stool, +insomnia- 2-3hrs of consecutive sleep, +sore throat, +headache, -n/v/d, no swelling of upper/lower extremities, no rash or neurological issues, +dizzy, - denies any chest pain and urinary hesitation (new). Patient reports being in good health prior to exposure. HOSPITAL COURSE: 74 yo patient who was treated for acute COVID 19 pneumonia and acute hypoxic respiratory failure from 9/21-9/24/2021. He is fully vaccinated with Moderna vaccine. The patient was treated with IV remdesivir and steroids. D-dimer negative for PE. He was weaned from supplemental oxygen. 02sat 96% on Room air. He was able to walk daily without any assistance. The patient was medically stable for discharge on 9/24/21. The patient will be monitored through home telehealth COVID 19 monitoring program post discharge. Patient in agreement to follow up plan and PCP appt on 7-10 days.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Dyspnoea exertional, Exposure to SARS-CoV-2
Clinical narrative: Narrative: 74yo M was admitted from the emergency room due to progressive shortness x 5 days after having a COVID exposure. Patient is fully vaccinated but reports approximately 10 days ago he was around a boy who was coughing a lot. Over the past 2-3 days his wife has been ill and plans to go now to get tested for covid. Patient reported taking otc cough medication and benadryl to assist with sleep, without any relief. Symptoms reported; +nonproductive cough, +wheezing, +DOE, sob, +subjective fever, +hot/cold flashes, right sided generalize pain to include right side of abdomen, decreased appetite, no food intake in 2-3d, 1 loose stool, +insomnia- 2-3hrs of consecutive sleep, +sore throat, +headache, -n/v/d, no swelling of upper/lower extremities, no rash or neurological issues, +dizzy, - denies any chest pain and urinary hesitation (new). Patient reports being in good health prior to exposure. HOSPITAL COURSE: 74 yo patient who was treated for acute COVID 19 pneumonia and acute hypoxic respiratory failure from 9/21-9/24/2021. He is fully vaccinated with Moderna vaccine. The patient was treated with IV remdesivir and steroids. D-dimer negative for PE. He was weaned from supplemental oxygen. 02sat 96% on Room air. He was able to walk daily without any assistance. The patient was medically stable for discharge on 9/24/21. The patient will be monitored through home telehealth COVID 19 monitoring program post discharge. Patient in agreement to follow up plan and PCP appt on 7-10 days.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Fibrin D dimer, Headache, Hypophagia, Insomnia
Clinical narrative: Narrative: 74yo M was admitted from the emergency room due to progressive shortness x 5 days after having a COVID exposure. Patient is fully vaccinated but reports approximately 10 days ago he was around a boy who was coughing a lot. Over the past 2-3 days his wife has been ill and plans to go now to get tested for covid. Patient reported taking otc cough medication and benadryl to assist with sleep, without any relief. Symptoms reported; +nonproductive cough, +wheezing, +DOE, sob, +subjective fever, +hot/cold flashes, right sided generalize pain to include right side of abdomen, decreased appetite, no food intake in 2-3d, 1 loose stool, +insomnia- 2-3hrs of consecutive sleep, +sore throat, +headache, -n/v/d, no swelling of upper/lower extremities, no rash or neurological issues, +dizzy, - denies any chest pain and urinary hesitation (new). Patient reports being in good health prior to exposure. HOSPITAL COURSE: 74 yo patient who was treated for acute COVID 19 pneumonia and acute hypoxic respiratory failure from 9/21-9/24/2021. He is fully vaccinated with Moderna vaccine. The patient was treated with IV remdesivir and steroids. D-dimer negative for PE. He was weaned from supplemental oxygen. 02sat 96% on Room air. He was able to walk daily without any assistance. The patient was medically stable for discharge on 9/24/21. The patient will be monitored through home telehealth COVID 19 monitoring program post discharge. Patient in agreement to follow up plan and PCP appt on 7-10 days.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Sick relative, Wheezing
Clinical narrative: Narrative: 74yo M was admitted from the emergency room due to progressive shortness x 5 days after having a COVID exposure. Patient is fully vaccinated but reports approximately 10 days ago he was around a boy who was coughing a lot. Over the past 2-3 days his wife has been ill and plans to go now to get tested for covid. Patient reported taking otc cough medication and benadryl to assist with sleep, without any relief. Symptoms reported; +nonproductive cough, +wheezing, +DOE, sob, +subjective fever, +hot/cold flashes, right sided generalize pain to include right side of abdomen, decreased appetite, no food intake in 2-3d, 1 loose stool, +insomnia- 2-3hrs of consecutive sleep, +sore throat, +headache, -n/v/d, no swelling of upper/lower extremities, no rash or neurological issues, +dizzy, - denies any chest pain and urinary hesitation (new). Patient reports being in good health prior to exposure. HOSPITAL COURSE: 74 yo patient who was treated for acute COVID 19 pneumonia and acute hypoxic respiratory failure from 9/21-9/24/2021. He is fully vaccinated with Moderna vaccine. The patient was treated with IV remdesivir and steroids. D-dimer negative for PE. He was weaned from supplemental oxygen. 02sat 96% on Room air. He was able to walk daily without any assistance. The patient was medically stable for discharge on 9/24/21. The patient will be monitored through home telehealth COVID 19 monitoring program post discharge. Patient in agreement to follow up plan and PCP appt on 7-10 days.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bicarbonate normal, Blood fibrinogen normal, Blood gases abnormal, Blood lactic acid, Blood pH increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/22/2020, Pfizer, dose #1 01/14/2021, Pfizer, dose #2 08/18 pt cc: exposure: unknown 08/18 COVID swab, result: detected 08/18 CXR impression: 1 portable AP view of the chest.No significant change. No coalescent lung consolidation. No pneumothorax. No pleural effusion. Cardiac silhouette within normal limits. No acute osseous abnormality seen. Clear lungs. 08/25 pt admit to ED cc: Decraesed O2 saturation, dx: COVID pneumonia LOS: 9 days 08/25 lactic acid result: 1.23 08/25 procalcitonin result: <0.05 08/25 PT/INR 18.3/ 1.63 08/25 DDIMER result: 0.28 8/25 BNP 168.7 08/25 ABG i-pH 7.52, iPCO2 30.7, i-PO2 68 - HCO3 24.9 08/25 SARS-COV-2 IGG result: 0.01 08/25 CXR impression: 1. Patchy bilateral lung opacities are likely related to underlying viral infection, mildly increased since August 21, 2021. 2. No effusion. No pneumothorax. 08/26 FIBRINOGEN result: 399 08/26 DDIMER result: 0.40 08/26 ESR result: 26 08/27 FIBRINOGEN result: 331 08/27 DDIMER result: 0.28 08/27 ESR result: 12 08/27 DDIMER result: 0.26 08/28 FIBRINOGEN result: 253 08/28 DDIMER result: 0.50 08/28 ESR 8 08/29 DDIMER result: 1.25 08/30 DDIMER result: 1.97 08/31 FIBRINOGEN result: 172 08/31 DDIMER result: 1.75 08/31 ESR result: <1 09/01 FIBRINOGEN result: 180 09/01 DDIMER result: 1.31 09/01 ESR result: <1 09/02 FIBRINOGEN result: 175 09/02 DDIMER result: 1.00 09/02 ESR <1 09/03 FIBRINOGEN result: 168 09/03 DDIMER result: 0.84 09/03 ESR result: <1 09/03 clinically resolved
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia, Chest X-ray normal, Fibrin D dimer
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/22/2020, Pfizer, dose #1 01/14/2021, Pfizer, dose #2 08/18 pt cc: exposure: unknown 08/18 COVID swab, result: detected 08/18 CXR impression: 1 portable AP view of the chest.No significant change. No coalescent lung consolidation. No pneumothorax. No pleural effusion. Cardiac silhouette within normal limits. No acute osseous abnormality seen. Clear lungs. 08/25 pt admit to ED cc: Decraesed O2 saturation, dx: COVID pneumonia LOS: 9 days 08/25 lactic acid result: 1.23 08/25 procalcitonin result: <0.05 08/25 PT/INR 18.3/ 1.63 08/25 DDIMER result: 0.28 8/25 BNP 168.7 08/25 ABG i-pH 7.52, iPCO2 30.7, i-PO2 68 - HCO3 24.9 08/25 SARS-COV-2 IGG result: 0.01 08/25 CXR impression: 1. Patchy bilateral lung opacities are likely related to underlying viral infection, mildly increased since August 21, 2021. 2. No effusion. No pneumothorax. 08/26 FIBRINOGEN result: 399 08/26 DDIMER result: 0.40 08/26 ESR result: 26 08/27 FIBRINOGEN result: 331 08/27 DDIMER result: 0.28 08/27 ESR result: 12 08/27 DDIMER result: 0.26 08/28 FIBRINOGEN result: 253 08/28 DDIMER result: 0.50 08/28 ESR 8 08/29 DDIMER result: 1.25 08/30 DDIMER result: 1.97 08/31 FIBRINOGEN result: 172 08/31 DDIMER result: 1.75 08/31 ESR result: <1 09/01 FIBRINOGEN result: 180 09/01 DDIMER result: 1.31 09/01 ESR result: <1 09/02 FIBRINOGEN result: 175 09/02 DDIMER result: 1.00 09/02 ESR <1 09/03 FIBRINOGEN result: 168 09/03 DDIMER result: 0.84 09/03 ESR result: <1 09/03 clinically resolved
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio increased, Lung opacity, Oxygen saturation decreased, PCO2 decreased, PO2 decreased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/22/2020, Pfizer, dose #1 01/14/2021, Pfizer, dose #2 08/18 pt cc: exposure: unknown 08/18 COVID swab, result: detected 08/18 CXR impression: 1 portable AP view of the chest.No significant change. No coalescent lung consolidation. No pneumothorax. No pleural effusion. Cardiac silhouette within normal limits. No acute osseous abnormality seen. Clear lungs. 08/25 pt admit to ED cc: Decraesed O2 saturation, dx: COVID pneumonia LOS: 9 days 08/25 lactic acid result: 1.23 08/25 procalcitonin result: <0.05 08/25 PT/INR 18.3/ 1.63 08/25 DDIMER result: 0.28 8/25 BNP 168.7 08/25 ABG i-pH 7.52, iPCO2 30.7, i-PO2 68 - HCO3 24.9 08/25 SARS-COV-2 IGG result: 0.01 08/25 CXR impression: 1. Patchy bilateral lung opacities are likely related to underlying viral infection, mildly increased since August 21, 2021. 2. No effusion. No pneumothorax. 08/26 FIBRINOGEN result: 399 08/26 DDIMER result: 0.40 08/26 ESR result: 26 08/27 FIBRINOGEN result: 331 08/27 DDIMER result: 0.28 08/27 ESR result: 12 08/27 DDIMER result: 0.26 08/28 FIBRINOGEN result: 253 08/28 DDIMER result: 0.50 08/28 ESR 8 08/29 DDIMER result: 1.25 08/30 DDIMER result: 1.97 08/31 FIBRINOGEN result: 172 08/31 DDIMER result: 1.75 08/31 ESR result: <1 09/01 FIBRINOGEN result: 180 09/01 DDIMER result: 1.31 09/01 ESR result: <1 09/02 FIBRINOGEN result: 175 09/02 DDIMER result: 1.00 09/02 ESR <1 09/03 FIBRINOGEN result: 168 09/03 DDIMER result: 0.84 09/03 ESR result: <1 09/03 clinically resolved
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Prothrombin time prolonged, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/22/2020, Pfizer, dose #1 01/14/2021, Pfizer, dose #2 08/18 pt cc: exposure: unknown 08/18 COVID swab, result: detected 08/18 CXR impression: 1 portable AP view of the chest.No significant change. No coalescent lung consolidation. No pneumothorax. No pleural effusion. Cardiac silhouette within normal limits. No acute osseous abnormality seen. Clear lungs. 08/25 pt admit to ED cc: Decraesed O2 saturation, dx: COVID pneumonia LOS: 9 days 08/25 lactic acid result: 1.23 08/25 procalcitonin result: <0.05 08/25 PT/INR 18.3/ 1.63 08/25 DDIMER result: 0.28 8/25 BNP 168.7 08/25 ABG i-pH 7.52, iPCO2 30.7, i-PO2 68 - HCO3 24.9 08/25 SARS-COV-2 IGG result: 0.01 08/25 CXR impression: 1. Patchy bilateral lung opacities are likely related to underlying viral infection, mildly increased since August 21, 2021. 2. No effusion. No pneumothorax. 08/26 FIBRINOGEN result: 399 08/26 DDIMER result: 0.40 08/26 ESR result: 26 08/27 FIBRINOGEN result: 331 08/27 DDIMER result: 0.28 08/27 ESR result: 12 08/27 DDIMER result: 0.26 08/28 FIBRINOGEN result: 253 08/28 DDIMER result: 0.50 08/28 ESR 8 08/29 DDIMER result: 1.25 08/30 DDIMER result: 1.97 08/31 FIBRINOGEN result: 172 08/31 DDIMER result: 1.75 08/31 ESR result: <1 09/01 FIBRINOGEN result: 180 09/01 DDIMER result: 1.31 09/01 ESR result: <1 09/02 FIBRINOGEN result: 175 09/02 DDIMER result: 1.00 09/02 ESR <1 09/03 FIBRINOGEN result: 168 09/03 DDIMER result: 0.84 09/03 ESR result: <1 09/03 clinically resolved
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Viral infection
Clinical narrative: Narrative: COVID infection following COVID vaccine series 12/22/2020, Pfizer, dose #1 01/14/2021, Pfizer, dose #2 08/18 pt cc: exposure: unknown 08/18 COVID swab, result: detected 08/18 CXR impression: 1 portable AP view of the chest.No significant change. No coalescent lung consolidation. No pneumothorax. No pleural effusion. Cardiac silhouette within normal limits. No acute osseous abnormality seen. Clear lungs. 08/25 pt admit to ED cc: Decraesed O2 saturation, dx: COVID pneumonia LOS: 9 days 08/25 lactic acid result: 1.23 08/25 procalcitonin result: <0.05 08/25 PT/INR 18.3/ 1.63 08/25 DDIMER result: 0.28 8/25 BNP 168.7 08/25 ABG i-pH 7.52, iPCO2 30.7, i-PO2 68 - HCO3 24.9 08/25 SARS-COV-2 IGG result: 0.01 08/25 CXR impression: 1. Patchy bilateral lung opacities are likely related to underlying viral infection, mildly increased since August 21, 2021. 2. No effusion. No pneumothorax. 08/26 FIBRINOGEN result: 399 08/26 DDIMER result: 0.40 08/26 ESR result: 26 08/27 FIBRINOGEN result: 331 08/27 DDIMER result: 0.28 08/27 ESR result: 12 08/27 DDIMER result: 0.26 08/28 FIBRINOGEN result: 253 08/28 DDIMER result: 0.50 08/28 ESR 8 08/29 DDIMER result: 1.25 08/30 DDIMER result: 1.97 08/31 FIBRINOGEN result: 172 08/31 DDIMER result: 1.75 08/31 ESR result: <1 09/01 FIBRINOGEN result: 180 09/01 DDIMER result: 1.31 09/01 ESR result: <1 09/02 FIBRINOGEN result: 175 09/02 DDIMER result: 1.00 09/02 ESR <1 09/03 FIBRINOGEN result: 168 09/03 DDIMER result: 0.84 09/03 ESR result: <1 09/03 clinically resolved
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Confusional state, Flushing, Hallucination, Headache
Clinical narrative: Confusion, Hallucinations, Headache, Sedation, Palpitations, Tachycardia, chest pain;numbness Narrative:  Approximately 1 hour post first Covid Moderna Vaccine patient went to emergency room with chest pain, numbness in arms racing heart, flushing and she was given prednisone, benedryl iv steroids iv remdesivir iv sent home on prednisone
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Palpitations, Tachycardia
Clinical narrative: Confusion, Hallucinations, Headache, Sedation, Palpitations, Tachycardia, chest pain;numbness Narrative:  Approximately 1 hour post first Covid Moderna Vaccine patient went to emergency room with chest pain, numbness in arms racing heart, flushing and she was given prednisone, benedryl iv steroids iv remdesivir iv sent home on prednisone
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Blood culture negative, Blood lactic acid, Brain natriuretic peptide increased, Chills, Computerised tomogram abdomen normal
Clinical narrative: Narrative: Patient presented to non-facility ED on date he received 3rd dose of COVID-19 vaccine with chief complain of rigors and shaking. He got the vaccine in the morning and became ill with a fever later in the afternoon. Patient found to have lactic acidosis. Given 2 L of fluids and 2 gm of IV rocephin due to fever of unknown origin. Due to rigors, fever and lactic acidosis admitted to hospital (9/3-9/7/21). Blood cultures negative. Initially started on Zosyn for possible pneumonia. His workup otherwise negative (clear CT of chest (pleural effusion), negative urine culture, negative acute respiratory panel, sputum culture with normal oral floral, CT abdomen and pelvis with no clear evidence of infection). Continued to have intermittent fevers. Slight productive cough so discharged on Augmentin. ID specialist felt this may possible be vaccine reaction with immunosuppression and multiple myeloma treatment. Discharged diagnoses = sepsis with unclear etiology, possibly due to vaccine reaction versus pneumonia, hypoxia with dyspnea and other chronic conditions.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax normal, Culture urine negative, Dyspnoea, Hypoxia, Lactic acidosis
Clinical narrative: Narrative: Patient presented to non-facility ED on date he received 3rd dose of COVID-19 vaccine with chief complain of rigors and shaking. He got the vaccine in the morning and became ill with a fever later in the afternoon. Patient found to have lactic acidosis. Given 2 L of fluids and 2 gm of IV rocephin due to fever of unknown origin. Due to rigors, fever and lactic acidosis admitted to hospital (9/3-9/7/21). Blood cultures negative. Initially started on Zosyn for possible pneumonia. His workup otherwise negative (clear CT of chest (pleural effusion), negative urine culture, negative acute respiratory panel, sputum culture with normal oral floral, CT abdomen and pelvis with no clear evidence of infection). Continued to have intermittent fevers. Slight productive cough so discharged on Augmentin. ID specialist felt this may possible be vaccine reaction with immunosuppression and multiple myeloma treatment. Discharged diagnoses = sepsis with unclear etiology, possibly due to vaccine reaction versus pneumonia, hypoxia with dyspnea and other chronic conditions.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Procalcitonin, Productive cough, Pyrexia, Respiratory pathogen panel
Clinical narrative: Narrative: Patient presented to non-facility ED on date he received 3rd dose of COVID-19 vaccine with chief complain of rigors and shaking. He got the vaccine in the morning and became ill with a fever later in the afternoon. Patient found to have lactic acidosis. Given 2 L of fluids and 2 gm of IV rocephin due to fever of unknown origin. Due to rigors, fever and lactic acidosis admitted to hospital (9/3-9/7/21). Blood cultures negative. Initially started on Zosyn for possible pneumonia. His workup otherwise negative (clear CT of chest (pleural effusion), negative urine culture, negative acute respiratory panel, sputum culture with normal oral floral, CT abdomen and pelvis with no clear evidence of infection). Continued to have intermittent fevers. Slight productive cough so discharged on Augmentin. ID specialist felt this may possible be vaccine reaction with immunosuppression and multiple myeloma treatment. Discharged diagnoses = sepsis with unclear etiology, possibly due to vaccine reaction versus pneumonia, hypoxia with dyspnea and other chronic conditions.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Sputum culture, Tremor, White blood cell count decreased
Clinical narrative: Narrative: Patient presented to non-facility ED on date he received 3rd dose of COVID-19 vaccine with chief complain of rigors and shaking. He got the vaccine in the morning and became ill with a fever later in the afternoon. Patient found to have lactic acidosis. Given 2 L of fluids and 2 gm of IV rocephin due to fever of unknown origin. Due to rigors, fever and lactic acidosis admitted to hospital (9/3-9/7/21). Blood cultures negative. Initially started on Zosyn for possible pneumonia. His workup otherwise negative (clear CT of chest (pleural effusion), negative urine culture, negative acute respiratory panel, sputum culture with normal oral floral, CT abdomen and pelvis with no clear evidence of infection). Continued to have intermittent fevers. Slight productive cough so discharged on Augmentin. ID specialist felt this may possible be vaccine reaction with immunosuppression and multiple myeloma treatment. Discharged diagnoses = sepsis with unclear etiology, possibly due to vaccine reaction versus pneumonia, hypoxia with dyspnea and other chronic conditions.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Condition aggravated, Dyspnoea exertional, Fatigue, Myalgia
Clinical narrative: Myalgia, CoughWheeze worsening of asthma, fatigue Narrative:  Prior to getting the COVID vaccine the patient's asthma was well controlled. Since getting the second dose of Moderna vaccine on 1/26/21 the patient's asthma has been severe. She reports 4 asthma attacks per week. She does a daily nebulizer treatment, and uses her rescue inhaler 5 times a day on average. She has shortness of breath with exertion. She has also experienced myalgia and fatigue since January. The patient has required EMS at least once due to an asthma attack.
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea
Clinical narrative: dyspnea Narrative: in observation for 24 hours
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Haematemesis, Pain
Clinical narrative: Headache, Myalgia, NauseaVomiting, GastricBleeding, Body itching, mouth numbness, palm of hand numbness  Narrative: Employee reports that she when to the ER 3 times at the advice of her PCP due to the amount of pain she was having and the last time was today 10/15/2021 when she started vomiting blood, Unknown amount. She was treated and released.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Renal cancer
Clinical narrative: Narrative: 74yo male patient with diagnose of left sided transitional cell ca of kidney died on 9/27/21. Pt treated at outside facility. Pt had received covid vaccines on 1/29/2021 & 2/19/2021 from outside hospital. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Computerised tomogram thorax abnormal, Cough, Dyspnoea, Pulmonary embolism
Clinical narrative: Narrative:  Patient is an 81 y/o male who received the COVID-19 booster vaccine on 9/30. On 10/1 he presented to the ED for SOB, tachycardia, and cough. Chest CT revealed small branch PE, and the patient was started on rivaroxaban 15 mg BID. He was d/c home on 10/4 and directed to continue rivaroxaban 15 mg BID x3 weeks then 20mg daily for at least 3 months.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Narrative:  Patient is an 81 y/o male who received the COVID-19 booster vaccine on 9/30. On 10/1 he presented to the ED for SOB, tachycardia, and cough. Chest CT revealed small branch PE, and the patient was started on rivaroxaban 15 mg BID. He was d/c home on 10/4 and directed to continue rivaroxaban 15 mg BID x3 weeks then 20mg daily for at least 3 months.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Death, End stage renal disease
Clinical narrative: Narrative:  76 yo male patient with diagnosis of end stage chronic kidney disease in full care by home hospice died at home with hospice on 10/1/21. Pt had received covid vaccines on 1/21/21 & 2/19/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Angiogram pulmonary abnormal, Aspartate aminotransferase increased, Blood bicarbonate normal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Blood fibrinogen increased, Blood gases abnormal, Blood lactic acid, Blood pH increased, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cholelithiasis, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Headache, Hemiparesis, Hepatitis, Hepatomegaly
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertransaminasaemia, Lung consolidation, Myalgia, PCO2 decreased, PO2 decreased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Pneumonitis, Procalcitonin, Pulmonary embolism, Pyrexia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate normal, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive, Troponin I increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/12. Pfizer. dose #1 06/02, Pfizer, dose #2 08/23 pt cc: fever, rhinorrea, left sided weakness , fatigue, cough, myalgias, chills, headache, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result: pending 09/08 pt admit to medicine cc: SOB dx: COVID-19 complicated with multifocal pneumonia/pneumonitis, acute hypoxemic resp failure, bilateral pulmonary embolism (PEs). Likely secondary to COVID-19 infection, transaminitis/chemical and/or COVID-19 induced hepatitis LOS:9 days 09/08 COVID swab, result: detected 09/08 DDIMER result: 60.11 09/08 LACTIC ACID result: 1.72 09/08 ABG result: i-pH 7.52, i-Pco2 31, i-PO2 69, i-HCO3 25.6 09/08 troponin i result: 0.061 09/08 CTA PE impression: 1. Several segmental and numerous subsegmental acute pulmonary emboli. 2. Extensive patchy bilateral crazy paving type consolidation, nonspecific but likely in keeping with reported COVID 19. 3. Possible 7 mm nodule left upper lobe, consider 6 month follow-up. 4. Other findings as above. 09/09 SARS-COV-2 Variant Sequencing result: pending 09/09 FIBRINOGEN result: 491 09/09 DDIMER result: 26.69 09/09 ESR result: 9 09/10 FIBRINOGEN result: 399 09/10 DDIMER result: 13;30 09/10 procalcitonin result: 0.24 09/10 ESR result: 11 09/10 SARS-COV-2 Variant Sequencing result: pending 09/11 DDIMER result: 6.85 09/12 FIBRINOGEN result: 300 09/12 DDIMER result: 5.42 09/12 procalcintonin result: 0.14 09/12 ESR result: 19 09/13 DDMER result: 4.67 09/13 US LIVER impression: mild hepatomegaly. No sonographic evidence of hepatic steatosis or focal liver lesion. No intra or extrahepatic biliary ductal dilation. Small amount of gallbladder sludge. No cholelithiasis. 09/14 DDIMER result: 3.760 09/15 DDIMER result: 2.37 09/27 ALT/AST result: 99/39